Company Overview and News

 
Cbus proposes 35 level tower near prominent CBD corner

2018-04-19 theage.com.au
Cbus Property is wasting no time redeveloping one of the city’s most under-utilised sites, which it bought seven months ago, off-market, for a reported price of more than $70 million.
Upvote Downvote

 
Cbus proposes 35 level tower near prominent CBD corner

2018-04-19 smh.com.au
Cbus Property is wasting no time redeveloping one of the city’s most under-utilised sites, which it bought seven months ago, off-market, for a reported price of more than $70 million.
Upvote Downvote

 
NIB: A Healthy Insurer For Your Portfolio

2018-02-26 seekingalpha
NIB Holdings Limited is a health insurance company in Australia with several years of successful growth.
Upvote Downvote

 
Calvary Wakefield private hospital and medical clinic sells for $50 million

2017-12-14 perthnow.com.au
A WELL known private Adelaide hospital has changed hands today for a price 20 per cent higher than its book value.
Upvote Downvote

 
TrustCapital Advisors sells five towers for $727.55 million

2017-11-17 theage.com.au
Singapore fund manager TrustCapital Advisors has finalised the sale of five major office buildings on Australia's east coast for $727.55 million.
Upvote Downvote

 
TrustCapital Advisors sells five towers for $727.55 million

2017-11-17 smh.com.au
Singapore fund manager TrustCapital Advisors has finalised the sale of five major office buildings on Australia's east coast for $727.55 million.
Upvote Downvote

 
Queen caught in tax bombshell

2017-11-05 perthnow.com.au
THE Australian market looks set to open higher after another week of gains on Wall Street with US equities climbing to record highs. At 0700 AEDT on Monday, the share price futures index was up 16 points, or 0.27 per cent, at 5,955.
Upvote Downvote

1
Australian Unity to refund $620,000 after ACCC found it 'moved goalposts' on benefits

2017-11-03 theage.com.au
A health fund will repay $620,000 in total to tens of thousands of members after an investigation found it had changed the rules on "fixed" dental benefits in likely breach of the law.
Upvote Downvote

1
Australian Unity to refund $620,000 after ACCC found it 'moved goalposts' on benefits

2017-11-03 smh.com.au
A health fund will repay $620,000 in total to tens of thousands of members after an investigation found it had changed the rules on "fixed" dental benefits in likely breach of the law.
Upvote Downvote

 
Woodside director to lead CEDA

2017-08-15 businessnews.com.au
Melinda Cilento has been chosen to succeed Stephen Martin as chief executive of the Committee for Economic Development of Australia.
Upvote Downvote

 
Medical emerges as a major new asset class for Perth's property market

2017-07-25 smh.com.au
GPs working out of new medical facilities near Perth's hospitals could be paying rent as high as a premium grade office block in the CBD, according to new analysis by Perth business intelligence company Y Research.
Upvote Downvote

 
It All Adds Up episode 3: The seven secrets to happiness from the 'dismal science'

2017-07-06 theage.com.au
And not just a dismal science, but "a dreary, desolate and, indeed, quite abject and distressing one."
Upvote Downvote

 
It All Adds Up episode 3: The seven secrets to happiness from the 'dismal science'

2017-07-06 smh.com.au
And not just a dismal science, but "a dreary, desolate and, indeed, quite abject and distressing one."
Upvote Downvote

 
Census religion figures are no guide to the future

2017-06-28 smh.com.au
Michael Hing says he is the everyday relatable Australian, according to the 2016 census. From The Feed on SBS Viceland, 7.30 weeknights.
Upvote Downvote

 
Howard's broad church leaned hard to the right

2017-06-28 smh.com.au
When John Howard said the Liberal Party was a broad church, it was always a statement of aspiration rather than a reality ("We need strong conservative voices – like me, says Abbott", June 28).
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...